Reductions in prostatic doses are associated with less acute morbidity in patients undergoing Pd-103 brachytherapy: Substantiation of the rationale for focal therapy

PURPOSE/OBJECTIVES: Interest in prostate dose reduction or focal treatment exists due to expected reductions in treatment morbidity. Prior analyses have not generally corroborated relationships between prostate or urethral dose and urinary toxicity after brachytherapy, but such analyses have been pe...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Brachytherapy
Auteurs principaux: Ferro, Adam, Bae, Hee Joon, Yenokyan, Gayane, Le, Yi, McNutt, Todd, Mian, Omar, Gergis, Carol, Haviland, Chloe, DeWeese, Theodore L., Song, Daniel Y.
Format: Artigo
Langue:Inglês
Publié: 2017
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5834355/
https://ncbi.nlm.nih.gov/pubmed/29174937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.brachy.2017.10.008
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires